An Immunotherapy Study Could Help Osteosarcoma Patients
An immunotherapy study on mice with cancer identified that Delta-24-ACT had a higher effectiveness rate than control treatments. Tumors developed more slowly and side effects were reduced. Pediatric osteosarcoma is a rare, but aggressive form of cancer that mainly affects…